Since 2017, The Biocodex Microbiota Foundation rewards national research initiatives which aim to understand the interaction between microbiota and different pathologies. By promoting scientists from around the world at a key moment in their career, the grant seeks to motivate researchers to continue to explore the world of gut microbiota.
The annual call for proposals is carried out in countries where Biocodex has a subsidiary presence. An independent local scientific committee – made up of individuals recognized for their expertise in the microbiota field – gathers all proposals and selects the winning project to be granted.
Biocodex Microbiota Foundation in collaboration with Biocodex Microbiota Institute put national winners in the spotlight through testimonies and interviews!
Since 2017, The Biocodex Microbiota Foundation rewards national research initiatives which aim to understand the interaction between microbiota and different pathologies. By promoting scientists from around the world at a key moment in their career, the grant seeks to motivate researchers.
Granted projects
2023
Bacterial extracellular vesicles as biomarker for Parkinson's disease
Microbiome manipulation to reduce psychopathology in Multiple Sclerosis
Effect of novel microbiota-derived octadecanoid lipid Mediators and their functional impact on the gut mucosa
Transmission of Antibiotic Resistance in the Breast-Intestine Axis and its Relationship with Early Neonatal Colonization in the Transitional Period
Time restricted eating modulates gut microbiome and metabolome to improve immunotherapy outcomes in African American (AA) patients with Head and Neck squamous cell cancer (HNSCC)
PEARL-UTI: Probing the Essential and Adaptive Role of gut, vaginal microbiomes, urobiomes and mucus-like niches in the development of urinary tract infections in early adulthood women: a translational investigation
Does COVID-19 in patients with ulcerative colitis lead to changes in the composition of the intestinal microbiota metabolome predosposing to symtoms of Irritable Bowel Syndrome?
2022
Assessment of the intestinal microbiome enterotype and the ability to break down starch in a weight reduction program using nutritional intervention and probiotic therapy in obese women
Evolution of the intestinal microbiome, inflammatory markers, and body composition across lactation stages in infants born to women with normal weight and overweight/obesity